Clinical Trial Update: T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating pembrolizumab efficacy in metastatic non-small cell lung cancer using T-cell repertoire sequencing; the study status is N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Ari Raphael | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING